<style face="normal" font="default" size="100%">594 SQZ-PBMC-HPV-101: Increased overall survival in a subset of patients with recurrent, locally advanced, or metastatic HPV16<sup>+</sup> tumors treated with cell-based vaccine, SQZ-PBMC-HPV</style>

Drupal-HighWire